Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Anteris Technologies Global Corp. ( (AVR) ) is now available.
On July 28, 2025, Anteris Technologies Global Corp. entered into an amended and restated master services agreement with Switchback Medical, LLC. This agreement involves Switchback providing various development and manufacturing services, including engineering and testing, under set terms and conditions. The agreement grants Switchback a limited license to use certain intellectual property of Anteris for manufacturing purposes, while Anteris retains all rights to the results of any testing and developed intellectual property. The agreement is set to expire on March 31, 2028, with automatic renewals unless terminated by either party.
The most recent analyst rating on (AVR) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Anteris Technologies Global Corp. stock, see the AVR Stock Forecast page.
More about Anteris Technologies Global Corp.
Average Trading Volume: 211,047
Technical Sentiment Signal: Strong Sell
Current Market Cap: $120.8M
For an in-depth examination of AVR stock, go to TipRanks’ Overview page.